NCT06539806View on ClinicalTrials.gov

Clinical Study Evaluating the Effect of Losartan

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 20, 2024

Primary Completion Date

August 10, 2026

Study Completion Date

August 20, 2026

Conditions
Pancreatic Cancer
Interventions
DRUG

Losartan 50mg Tab

The efficacy of losartan on response rate in both metastatic and locally advanced pancreatic cancer patients

Trial Locations (1)

Unknown

RECRUITING

Tanta University Hospital, Tanta

All Listed Sponsors
lead

Tanta University

OTHER